Final NICE nod for Takeda’s Adcetris in Hodgkin’s lymphoma

15th June 2017 Uncategorised 0

Certain patients with Hodgkin’s Lymphoma living in England and Wales can now expect routine access to Takeda’s Adcetris on the NHS after NICE deemed the drug a cost-effective use of resources in some scenarios.

More: Final NICE nod for Takeda’s Adcetris in Hodgkin’s lymphoma
Source: News